Eli Lilly (LLY) EPS (Diluted) (2009 - 2026)
Eli Lilly (LLY) reported EPS (Diluted) of $7.22 for Q3 2026, up 16.2% from $6.21 a year earlier but down 9.0% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) EPS (Diluted) (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Eli Lilly's EPS (Diluted) came in at $30.87, up 50.7% year-over-year; for FY2025, it was $22.95, up 95.9% from FY2024.
- EPS (Diluted) has a five-year compound annual growth rate of 27.6% (FY2020 to FY2025).
- By year, EPS (Diluted) came in at $11.71 in FY2024 (+101.9%), $5.80 in FY2023 (-16.0%), $6.90 in FY2022 (+12.8%) and $6.12 in FY2021 (-9.8%).
- Five-year quarterly EPS (Diluted) spans a low of -$0.06 in Q3 2023 and a high of $8.26 in Q1 2026.
- Year over year, EPS (Diluted) has now increased in each of the last eight quarters, with growth averaging 119.9% over the last eight quarters.
- The high point for year-over-year EPS (Diluted) in five years was Q3 2025 (growth of 479.4%); the low point was Q2 2022 (a decline of 30.9%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $7.94 (Q2 2026), $8.26 (Q1 2026) and $7.38 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 7.22 |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.09 |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.38 |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 2.04 |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 1.67 |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 1.60 |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 7.08 |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.94 |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 0.56 |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 2.56 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.22 |
| Jun 30, 2026 | 7.94 |
| Mar 31, 2026 | 8.26 |
| Dec 31, 2025 | 7.38 |
| Sep 30, 2025 | 6.21 |
| Jun 30, 2025 | 6.29 |
| Mar 31, 2025 | 3.06 |
| Dec 31, 2024 | 4.88 |
| Sep 30, 2024 | 1.07 |
| Jun 30, 2024 | 3.28 |
| Mar 31, 2024 | 2.48 |
| Dec 31, 2023 | 2.42 |
| Sep 30, 2023 | -0.06 |
| Jun 30, 2023 | 1.95 |
| Mar 31, 2023 | 1.49 |
| Dec 31, 2022 | 2.14 |
| Sep 30, 2022 | 1.61 |
| Jun 30, 2022 | 1.05 |
| Mar 31, 2022 | 2.10 |
| Dec 31, 2021 | 1.89 |
API Access
Eli Lilly EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();